tranexamic acid has been researched along with Erythema in 14 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Studies have revealed reduction of erythema by oral tranexamic acid; however, there has been no direct comparison to placebo." | 9.41 | Effect of oral tranexamic acid on erythema index in patients with melasma. ( Nguyen, J; Paul, E; Rajgopal Bala, H; Rodrigues, M; Ross, A; Wong, CC, 2021) |
| "In this prospective pilot study, we evaluated the efficacy and safety for a novel combination therapy based on low-fluence Q-switched 1064 nm Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's melanosis." | 7.85 | A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis. ( Choi, SC; Jung, JY; Kwon, HH; Kwon, IH; Ohn, J; Park, GH; Park, HY; Suh, DH, 2017) |
| "Acne vulgaris is a common skin disease that is more common in young population and it can be associated with some sequels after resolving the lesions." | 7.30 | Evaluating the effect of tranexamic acid as mesotherapy on persistent post-acne erythema: A before and after study. ( Abouie, A; Bazargan, AS; Gheisari, M; Mirahmadi, S; Taheri, A; Ziaeifar, E, 2023) |
| "We included 20 patients, having erythematotelangiectatic rosacea." | 6.90 | The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea. ( Bageorgou, F; Kontochristopoulos, G; Tzanetakou, V; Vasalou, V, 2019) |
| "Post-acne hyperpigmentation is a common undesirable sequela of acne vulgaris that causes distress for many patients." | 5.62 | Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation. ( Abdel Hay, R; Elmasry, MF; Salim, H; Tawfic, SO, 2021) |
| " Studies have revealed reduction of erythema by oral tranexamic acid; however, there has been no direct comparison to placebo." | 5.41 | Effect of oral tranexamic acid on erythema index in patients with melasma. ( Nguyen, J; Paul, E; Rajgopal Bala, H; Rodrigues, M; Ross, A; Wong, CC, 2021) |
| "In this prospective pilot study, we evaluated the efficacy and safety for a novel combination therapy based on low-fluence Q-switched 1064 nm Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's melanosis." | 3.85 | A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis. ( Choi, SC; Jung, JY; Kwon, HH; Kwon, IH; Ohn, J; Park, GH; Park, HY; Suh, DH, 2017) |
| "Acne vulgaris is a common skin disease that is more common in young population and it can be associated with some sequels after resolving the lesions." | 3.30 | Evaluating the effect of tranexamic acid as mesotherapy on persistent post-acne erythema: A before and after study. ( Abouie, A; Bazargan, AS; Gheisari, M; Mirahmadi, S; Taheri, A; Ziaeifar, E, 2023) |
| "Treatment of melasma is challenging." | 3.11 | A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma. ( Debasmita, B; Ipsita, D; Ishan, A; Raj, C, 2022) |
| "Tranexamic acid (TXA) has emerged as a potential treatment for melasma." | 3.01 | The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial. ( El Hadidi, H; Mosaad, R; Ragab, N, 2021) |
| "We included 20 patients, having erythematotelangiectatic rosacea." | 2.90 | The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea. ( Bageorgou, F; Kontochristopoulos, G; Tzanetakou, V; Vasalou, V, 2019) |
| "Tranexamic acid (TA) is a relatively new brightening agent that interferes with keratinocyte-melanocyte interactions." | 2.87 | Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. ( Darayesh, M; Heiran, A; Saki, N, 2018) |
| "Melasma is a highly prevalent, chronic, and pigmentary disorder." | 2.58 | Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis. ( Fang, QQ; Gao, J; Tan, WQ; Wang, XW; Zhang, L; Zhao, QM; Zhao, WY, 2018) |
| "Post-acne hyperpigmentation is a common undesirable sequela of acne vulgaris that causes distress for many patients." | 1.62 | Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation. ( Abdel Hay, R; Elmasry, MF; Salim, H; Tawfic, SO, 2021) |
| "Tranexamic acid (TA) is a traditional plasmin inhibitor, and its role in the renovation of damaged skin has become the topic of a lot of research." | 1.40 | Tranexamic acid accelerates skin barrier recovery and upregulates occludin in damaged skin. ( Wang, XM; Wu, PL; Yang, LJ; Yuan, C, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Debasmita, B | 1 |
| Raj, C | 1 |
| Ishan, A | 1 |
| Ipsita, D | 1 |
| Bazargan, AS | 1 |
| Ziaeifar, E | 1 |
| Abouie, A | 1 |
| Mirahmadi, S | 1 |
| Taheri, A | 1 |
| Gheisari, M | 1 |
| Jakhar, D | 1 |
| Kaur, I | 1 |
| Nguyen, J | 1 |
| Rajgopal Bala, H | 1 |
| Ross, A | 1 |
| Wong, CC | 1 |
| Paul, E | 1 |
| Rodrigues, M | 1 |
| El Hadidi, H | 1 |
| Mosaad, R | 1 |
| Ragab, N | 1 |
| Tawfic, SO | 1 |
| Abdel Hay, R | 1 |
| Salim, H | 1 |
| Elmasry, MF | 1 |
| Xu, Y | 1 |
| Ma, R | 1 |
| Juliandri, J | 1 |
| Wang, X | 1 |
| Xu, B | 1 |
| Wang, D | 1 |
| Lu, Y | 1 |
| Zhou, B | 1 |
| Luo, D | 1 |
| Saki, N | 1 |
| Darayesh, M | 1 |
| Heiran, A | 1 |
| Bageorgou, F | 1 |
| Vasalou, V | 1 |
| Tzanetakou, V | 1 |
| Kontochristopoulos, G | 1 |
| Zhang, L | 1 |
| Tan, WQ | 1 |
| Fang, QQ | 1 |
| Zhao, WY | 1 |
| Zhao, QM | 1 |
| Gao, J | 1 |
| Wang, XW | 1 |
| Yuan, C | 1 |
| Wang, XM | 1 |
| Yang, LJ | 1 |
| Wu, PL | 1 |
| Kwon, HH | 1 |
| Ohn, J | 1 |
| Suh, DH | 1 |
| Park, HY | 1 |
| Choi, SC | 1 |
| Jung, JY | 1 |
| Kwon, IH | 1 |
| Park, GH | 1 |
| Chae, JB | 1 |
| Yang, SH | 1 |
| Byun, SY | 1 |
| Choi, HR | 1 |
| Shin, JW | 1 |
| Park, KC | 1 |
| Kanechorn Na Ayuthaya, P | 1 |
| Niumphradit, N | 1 |
| Manosroi, A | 1 |
| Nakakes, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid Versus Fractional CO2 Laser in Post-inflammatory Hyperpigmentation in Acne Patients[NCT03765021] | 25 participants (Anticipated) | Interventional | 2018-12-31 | Not yet recruiting | |||
| Comparing Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment[NCT03899233] | Phase 4 | 25 participants (Anticipated) | Interventional | 2019-04-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Erythema
| Article | Year |
|---|---|
Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Case-Control Studies; Erythema; Humans; Melanins; Melanosis; Middle Aged; Publica | 2018 |
8 trials available for tranexamic acid and Erythema
| Article | Year |
|---|---|
A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Topics: Erythema; Humans; Lasers, Solid-State; Melanosis; Prospective Studies; Tranexamic Acid; Treatment Ou | 2022 |
Evaluating the effect of tranexamic acid as mesotherapy on persistent post-acne erythema: A before and after study.
Topics: Acne Vulgaris; Erythema; Humans; Mesotherapy; Tranexamic Acid; Treatment Outcome | 2023 |
Effect of oral tranexamic acid on erythema index in patients with melasma.
Topics: Administration, Oral; Adult; Dermatologic Agents; Erythema; Humans; Melanosis; Middle Aged; Severity | 2021 |
The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
Topics: Administration, Cutaneous; Erythema; Female; Humans; Melanosis; Microinjections; Tranexamic Acid; Tr | 2021 |
Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: A randomized, self-controlled, split-face study.
Topics: Administration, Cutaneous; Adult; Antifibrinolytic Agents; China; Elasticity; Erythema; Face; Female | 2017 |
Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
Topics: Administration, Topical; Adult; Erythema; Face; Female; Humans; Hydroquinones; Melanins; Melanosis; | 2018 |
The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea.
Topics: Acupuncture Therapy; Adult; Aged; Antifibrinolytic Agents; Bandages; Combined Modality Therapy; Derm | 2019 |
Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Topics: Administration, Cutaneous; Adult; Antifibrinolytic Agents; Asian People; Bleaching Agents; Double-Bl | 2012 |
5 other studies available for tranexamic acid and Erythema
| Article | Year |
|---|---|
Topical 5% tranexamic acid for acne-related postinflammatory erythema.
Topics: Acne Vulgaris; Administration, Cutaneous; Antifibrinolytic Agents; Erythema; Humans; Tranexamic Acid | 2020 |
Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation.
Topics: Acne Vulgaris; Cicatrix; Erythema; Humans; Hyperpigmentation; Lasers, Gas; Tranexamic Acid; Treatmen | 2021 |
Tranexamic acid accelerates skin barrier recovery and upregulates occludin in damaged skin.
Topics: Adult; Aged; Antifibrinolytic Agents; Erythema; Female; Humans; Male; Melanins; Middle Aged; Occludi | 2014 |
A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Combined Modality Therapy; Erythema; Facial | 2017 |
The effects of hydroporation on melasma with anti-aging cocktail.
Topics: Antifibrinolytic Agents; beta-Glucans; Collagen Type IV; Copper; Dermatologic Agents; Dermis; Drug C | 2017 |